David C Montefiori

David C Montefiori

UNVERIFIED PROFILE

Are you David C Montefiori?   Register this Author

Register author
David C Montefiori

David C Montefiori

Publications by authors named "David C Montefiori"

Are you David C Montefiori?   Register this Author

100Publications

3470Reads

20Profile Views

Antibody Responses Elicited by Immunization with BG505 Trimer Immune Complexes.

J Virol 2019 Oct 30;93(20). Epub 2019 Sep 30.

Department of Medicine, University of California Irvine, School of Medicine, Irvine, California, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.01188-19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798112PMC
October 2019

A Single Substitution in gp41 Modulates the Neutralization Profile of SHIV during In Vivo Adaptation.

Cell Rep 2019 May;27(9):2593-2607.e5

Comprehensive AIDS Research Center, Beijing Advanced Innovation Center for Structural Biology, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2019.04.108DOI Listing
May 2019

Synthetic HIV V3 Glycopeptide Immunogen Carrying a N334 N-Glycan Induces Glycan-Dependent Antibodies with Promiscuous Site Recognition.

J Med Chem 2018 11 8;61(22):10116-10125. Epub 2018 Nov 8.

Department of Chemistry and Biochemistry , University of Maryland , College Park , Maryland 20742 , United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jmedchem.8b01290DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283719PMC
November 2018

Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virus.

Sci Rep 2018 06 12;8(1):8952. Epub 2018 Jun 12.

Virginia-Maryland College of Veterinary Medicine, University of Maryland, College Park, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-27433-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997738PMC
June 2018

Multivalent Antigen Presentation Enhances the Immunogenicity of a Synthetic Three-Component HIV-1 V3 Glycopeptide Vaccine.

ACS Cent Sci 2018 May 7;4(5):582-589. Epub 2018 May 7.

Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acscentsci.8b00060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968512PMC
May 2018

Neutralization tiers of HIV-1.

Curr Opin HIV AIDS 2018 03;13(2):128-136

Beth Israel Deaconess Medical Center, Harvard University, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COH.0000000000000442DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802254PMC
March 2018

Synthetic Three-Component HIV-1 V3 Glycopeptide Immunogens Induce Glycan-Dependent Antibody Responses.

Cell Chem Biol 2017 12 26;24(12):1513-1522.e4. Epub 2017 Oct 26.

Department of Chemistry and Biochemistry, University of Maryland, College Park, MD 20742, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chembiol.2017.09.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741509PMC
December 2017

Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV.

Hum Vaccin Immunother 2017 11 26;13(11):2726-2737. Epub 2017 Sep 26.

a Department of Microbiology and Immunology , The University of Melbourne, Peter Doherty Institute for Infection and Immunity , Victoria , Australia.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/21645515.2017.1
Publisher Site
http://dx.doi.org/10.1080/21645515.2017.1368935DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703365PMC
November 2017

Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches.

Immunity 2017 06;46(6):1073-1088.e6

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA 02139, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2017.05.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483234PMC
June 2017

Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy.

Sci Rep 2017 04 7;7:46308. Epub 2017 Apr 7.

State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing 102206, PR China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep46308DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384219PMC
April 2017